Atlas Trials

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Clinical trial NCT03947489 · COMPLETED

Trial details

NCT number
NCT03947489
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-03-04
Primary completion
2019-05-06
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.